Comparison between SAR Televenture IPO and Sunrest Lifescience IPO.
SAR Televenture IPO is a SME Fixed Price IPO proposed to list at NSE SME while Sunrest Lifescience IPO is a SME Fixed Price proposed to list at NSE SME.
| SAR Televenture IPO | Sunrest Lifescience IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt.Ltd. | Mark Corporate Advisors Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | R.K.Stock Holding Pvt.Ltd. | Svcm Securities Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of SAR Televenture IPO is up to ₹23.49 Cr whereas the issue size of the Sunrest Lifescience IPO is up to ₹10.30 Cr. The final issue price of SAR Televenture IPO is ₹55.00 per share and of Sunrest Lifescience IPO is ₹84.00 per share.
| SAR Televenture IPO | Sunrest Lifescience IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹10 per share |
| Issue Price (Lower) | ₹52.00 per share | |
| Issue Price (Upper) | ₹55.00 per share | |
| Issue Price (Final) | ₹55.00 per share | ₹84.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 1600 shares |
| Fresh Issue Size | 42,70,000 shares | 12,25,600 shares |
| Fresh Issue Size (Amount) | up to ₹23.49 Cr | up to ₹10.30 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 42,70,000 shares | 12,25,600 shares |
| Issue Size Total (Amount) | up to ₹23.49 Cr | up to ₹10.30 Cr |
SAR Televenture IPO opens on Nov 01, 2023, while Sunrest Lifescience IPO opens on Nov 07, 2023. The closing date of SAR Televenture IPO and Sunrest Lifescience IPO is Nov 03, 2023, and Nov 09, 2023, respectively.
| SAR Televenture IPO | Sunrest Lifescience IPO | |
|---|---|---|
| Anchor Bid Date | Oct 31, 2023 | |
| Issue Open | Nov 01, 2023 | Nov 07, 2023 |
| Issue Close | Nov 03, 2023 | Nov 09, 2023 |
| Basis Of Allotment (Tentative) | Nov 06, 2023 | Nov 15, 2023 |
| Initiation of Refunds (Tentative) | Nov 07, 2023 | Nov 16, 2023 |
| Credit of Share (Tentative) | Nov 07, 2023 | Nov 17, 2023 |
| Listing date (Tentative) | Nov 08, 2023 | Nov 20, 2023 |
| Anchor Lockin End date 1 | Dec 06, 2023 | |
| Anchor Lockin End date 2 | Feb 04, 2024 |
SAR Televenture IPO P/E ratio is 0.6, as compared to Sunrest Lifescience IPO P/E ratio of 12.33.
| SAR Televenture IPO | Sunrest Lifescience IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 87.80 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 69.91 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 0.6 | 12.33 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹82.50 Cr. | ₹36.05 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 53% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 98% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.65 | 0.64 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹91.08 | ₹6.81 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 32.95% | 65.59% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the SAR Televenture IPO Retail Individual Investors (RII) are offered 15,00,000 shares while in Sunrest Lifescience IPO retail investors are offered 15,00,000 shares. Qualified Institutional Buyers (QIB) are offered 8,48,000 shares in SAR Televenture IPO and in Sunrest Lifescience IPO.
| SAR Televenture IPO | Sunrest Lifescience IPO | |
|---|---|---|
| Anchor Investor Reservation | 12,72,000 shares | |
| Market Maker Reservation | 2,30,000 shares | 65,600 shares |
| QIB | 8,48,000 shares | |
| NII | 6,50,000 shares | 6,12,800 shares |
| RII | 15,00,000 shares | 6,12,800 shares |
| Employee | ||
| Others | ||
| Total | 42,70,000 shares | 12,25,600 shares |
SAR Televenture IPO subscribed 288.09x in total, whereas Sunrest Lifescience IPO subscribed 48.54x.
| SAR Televenture IPO | Sunrest Lifescience IPO | |
|---|---|---|
| QIB (times) | 77.00x | |
| NII (times) | 715.77x | 29.17x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 222.10x | 65.74x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 288.09x | 48.54x |
